Latest News & Features
Big Pharma
Phase one of the US-China trade deal agreed last week is a major win for pharmaceutical companies, lawyers have told LSIPR. 21 January 2020
Medtech
The US Patent and Trademark Office has denied an inter partes review petition from Edwards Lifesciences, which argued that certain claims relating to Abbott’s MitraClip mitral valve repair device are unpatentable. 21 January 2020
Americas
A US judge has thrown out a lawsuit accusing US biotechnology companies Illumina and Affymetrix of a “complex, multi-decade concerted effort” to conceal the theft of trade secrets in the 1990s. 17 January 2020
Big Pharma
Global healthcare provider Eli Lilly has agreed to buy Dermira, a biopharmaceutical company, for $1.1 billion, giving it access to a late-stage atopic dermatitis drug and allowing it to challenge Sanofi’s already fully-licenced dupilumab. 16 January 2020
Europe
Haseltine Lake Kempner has added Jo Deas as a partner to its chemistry and life sciences team, effective January 20. 16 January 2020
Europe
In a dramatic reversal, a European Patent Office’s board of appeal has upheld the revocation of a Broad Institute CRISPR/Cas9 patent. 16 January 2020
Big Pharma
A former Genentech employee has pleaded guilty to a reduced charge after offering "superseding information" to the FBI as part of an ongoing trade secrets investigation. 16 January 2020
Americas
Gilead and its alleged co-conspirators Bristol-Myers Squibb, Japan Tobacco, and Johnson & Johnson have been accused of engaging in a long-running scheme to suppress competition in the market for HIV prevention therapies. 16 January 2020
Europe
The European Patent Office intends to refer questions in the Broad Institute’s ongoing CRISPR patent case to the enlarged board of appeal, meaning the case is set to drag out further. 15 January 2020
Europe
The first day of a landmark hearing on CRISPR ownership dealt nearly exclusively with untangling linguistic arguments, lawyers following the proceedings told LSIPR. 14 January 2020